Document is current
Any future updates will be listed below
-
Authors
Hwang, Jason T. K. https://orcid.org/0000-0001-5191-0950
Dammling, Chad
McCord, Christina https://orcid.org/0000-0002-4541-2282
McGuire, Taylor
Park, E. Peter
Filkowski, Jody
Shaw, Eileen
McMullen, Suzanne
Nwigwe, Adaeze
Ekwaru, J. Paul
McGaw, W. Tim
Lung, Kevin E.
Seikaly, Hadi
Renick, Barrie
Lin, Diana M.
Morlandt, Anthony
Pritzker, Kenneth H.
Darling, Mark R. https://orcid.org/0000-0002-5404-2201
-
Funding
Funding for this research was provided by:
Proteocyte Diagnostics
Proteocyte Diagnostics
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 21 October 2024
First Online: 29 October 2024
Declarations
:
: JF, ES, SM, AN, and PE are employed by Medlior, which received funding for the study from Proteocyte Diagnostics Inc. JH is a current employee of Proteocyte Diagnostics Inc. JH, KP, KL, BR, and AM are holders of equity interest in Proteocyte Diagnostics Inc. DL is a member of the Clinical Advisory Board of Proteocyte Diagnostics Inc. MD, CM, WTM, TM, EPP, and CD have no conflicts to declare.
: The study complied with the Helsinki Declaration and all applicable laws regarding subject privacy, and ethical approval was obtained from all of the sites included in the study (Health Research Ethics Board of Alberta–Cancer, Advarra Institutional Review Board, and UAB Institutional Review Board). No direct subject contact or collection of additional subject data occurred.
